The findings were reported in Science Translational Medicine. The researchers wanted to measure autoantibody levels in nasal ...

A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally cause milder symptoms, those with co-morbidities are still at an exponentially ...

It provides a more precise prediction than currently available of how serious the case is by focusing on autoantibodies in ...

In 2025, children within the TEDDY study will submit their final samples at research clinics in Sweden, Finland, Germany and ...

Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced its participation at the American College of Rheumatology (ACR) Convergence 2024, taking place in ...

Also early in 2024, researchers uncovered a specific autoantibody signature that was evident in some MS patients 5 years ...

Bollywood actor Arjun Kapoor opened up about his diagnosis with Hashimoto’s disease an autoimmune thyroid condition Read to ...

US endocrinologists are favoring antithyroid drugs over radioactive iodine in initial Graves’ disease treatment, and new ...

A study from Emory University reveals that autoantibodies found in the nasal cavity can help predict and improve COVID-19 recovery. The research indicates that these antibodies regulate inflammation ...

COVID-19 presents a broad range of symptoms, varying in intensity from mild to severe and even life-threatening.

New research is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment plans.